Effects of liposomal bupivacaine in preoperative fascia iliac block on postoperative pain and delirium in elderly patients undergoing hip fracture surgery: a study protocol for a randomised, parallel controlled prospective clinical study

Hao,Y.,Li,W.,Zheng,M.,Li,X.,Wu,X.,Yu,Z.,Liu,S.,Li,J.,Xu,H.
DOI: https://doi.org/10.1136/bmjopen-2023-079067
IF: 3.006
2024-01-07
BMJ Open
Abstract:Introduction Postoperative delirium (POD) is the most common acute fluctuating mental state change after hip fractures in older adults. Postoperative pain is a Grade A risk factor for POD and is closely related to the prognosis of patients undergoing hip fracture surgery. The fascia iliac block has a definite analgesic effect and few side effects, and several studies have reported that it reduces the occurrence of POD in patients undergoing general anaesthesia for hip fracture surgery. Liposomal bupivacaine is a local anaesthetic with a long half-life that significantly reduces the use of opioids and is conducive to patient prognosis and recovery. However, whether regional nerve block analgesia can decrease the occurrence of POD in elderly patients undergoing hip fracture surgery has not been reported. Methods and analysis This is a single-blinded, randomised, parallel-controlled prospective clinical study. Participants will be randomly assigned preoperatively to either the liposomal bupivacaine (ie, Exparel) or ropivacaine groups by block randomisation. Then, the occurrence of POD (primary outcome) and postoperative pain (secondary outcome) will be evaluated. Ethics and dissemination This research protocol complies with the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2013 guidelines and is approved by the Ethics Committee of Shanghai General Hospital (ID 2023–437). The original data are expected to be released in July 2029 on the ResMan original data-sharing platform (IPD-sharing platform) of the China Clinical Trial Registry, which can be viewed on the following website: http://www.medresman.org.cn. PROSPERO registration number ChiCTR2300074022.
medicine, general & internal
What problem does this paper attempt to address?
This paper aims to explore the effects of preoperative fascia iliaca block with liposomal bupivacaine on postoperative pain and postoperative delirium in hip fracture surgery. Specifically, the main objective of the study is to evaluate the effect of liposomal bupivacaine in preventing postoperative delirium (POD), and the secondary objective is to evaluate its role in relieving postoperative pain. ### Research Background - **Postoperative Delirium (POD)**: POD is the most common acute mental state change in elderly patients after hip fracture surgery, manifested as decreased consciousness and attention disorders. Postoperative pain is an important risk factor for POD and is closely related to the patient's prognosis. - **Fascia Iliaca Block (FIB)**: FIB has a definite analgesic effect and few side effects. Previous studies have shown that it can reduce the incidence of POD in patients undergoing hip fracture surgery under general anesthesia. - **Liposomal Bupivacaine**: This is a long - acting local anesthetic with a half - life of 24 - 34 hours, and a single injection can provide an analgesic effect for about 72 hours. Previous studies have shown that using liposomal bupivacaine for pressure - tube block can reduce postoperative pain and the use of opioids and shorten the length of hospital stay. ### Research Objectives - **Primary Outcome Indicator**: The incidence of POD within 7 days after surgery. - **Secondary Outcome Indicator**: Changes in postoperative pain levels. ### Research Design - **Trial Type**: This is a prospective, single - blind, randomized, parallel - controlled clinical trial. - **Grouping Method**: Participants will be randomly assigned to the liposomal bupivacaine group or the ropivacaine group by block randomization method. - **Intervention Measures**: Participants in both groups will receive a single FIB under the guidance of B - ultrasound 1 hour before surgery. The liposomal bupivacaine group will receive 20 mL of liposomal bupivacaine (266 mg), while the ropivacaine group will receive 20 mL of ropivacaine (75 mg). ### Conclusion This study hopes to provide a more effective analgesic plan for elderly patients undergoing hip fracture surgery by evaluating the effects of liposomal bupivacaine in preventing postoperative delirium and relieving postoperative pain, thereby improving postoperative recovery and quality of life.